On July 11, 2023, the U.S. Food and Drug Administration published a letter to healthcare providers stating that, based on its review of the totality of the available data and analyses,.
/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific.
/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific.